Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
877.85
1,032.32
1,071.54
793.03
284.06
253.70
237.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
877.85
1,032.32
1,071.54
793.03
284.06
253.70
237.55
Raw Material Cost
293.74
302.77
397.15
351.62
203.19
179.51
156.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
80.80
95.33
92.90
66.30
25.44
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.86
3.55
4.06
0.53
0.56
2.12
0.75
Selling and Distribution Expenses
465.83
606.91
560.62
362.29
84.97
68.66
61.51
Other Expenses
-5.94
-7.35
-6.92
-4.20
-2.07
0.24
0.53
Total Expenditure (Excl Depreciation)
783.85
935.04
985.56
738.72
293.46
252.74
224.03
Operating Profit (PBDIT) excl Other Income
94
97.30000000000001
86
54.3
-9.399999999999999
1
13.5
Other Income
-3.76
11.36
19.14
14.58
5.05
7.15
8.74
Operating Profit (PBDIT)
128.60
144.31
131.04
92.78
18.22
25.32
39.94
Interest
2.86
3.55
4.06
0.53
0.56
2.12
0.75
Exceptional Items
-0.00
-0.21
0.00
0.90
0.16
0.13
0.69
Gross Profit (PBDT)
584.11
729.55
674.39
441.41
80.87
74.19
81.03
Depreciation
44.60
38.80
29.96
27.01
22.56
19.50
19.84
Profit Before Tax
81.15
101.76
97.02
66.14
-4.75
3.82
20.03
Tax
15.78
51.68
13.17
17.49
1.55
0.54
4.67
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
43.95
24.48
61.65
38.79
-9.11
1.83
12.78
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
43.95
24.48
61.65
38.79
-9.11
1.83
12.78
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
21.41
25.60
22.20
9.87
2.81
1.45
2.59
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
65.36
50.08
83.85
48.65
-6.30
3.28
15.36
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
708.45
670.45
633.71
829.38
720.25
729.36
730.56
Earnings per share (EPS)
0.14
0.08
0.2
0.13
-0.03
0.01
0.04
Diluted Earnings per share
0.14
0.08
0.2
0.13
-0.03
0.01
0.04
Operating Profit Margin (Excl OI)
10.0%
9.12%
7.65%
6.45%
-3.31%
-0.53%
4.78%
Gross Profit Margin
14.32%
13.62%
11.85%
11.75%
6.27%
9.19%
16.78%
PAT Margin
5.01%
2.37%
5.75%
4.89%
-3.21%
0.72%
5.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -14.96% vs -3.66% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 30.54% vs -40.29% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -0.38% vs 18.77% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -17.14% vs -14.63% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
877.85
0
877.85
Other Operating Income
0.00
0.00
0.00
Total Operating income
877.85
0
877.85
Raw Material Cost
293.74
0
293.74
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
80.80
0
80.80
Power Cost
0
0
0.00
Manufacturing Expenses
2.86
0
2.86
Selling and Distribution Expenses
465.83
0
465.83
Other Expenses
-5.94
0.00
-5.94
Total Expenditure (Excl Depreciation)
783.85
0
783.85
Operating Profit (PBDIT) excl Other Income
94.00
0.00
94.00
Other Income
-3.76
0
-3.76
Operating Profit (PBDIT)
128.60
0
128.60
Interest
2.86
0
2.86
Exceptional Items
-0.00
0
-0.00
Gross Profit (PBDT)
584.11
0
584.11
Depreciation
44.60
0
44.60
Profit Before Tax
81.15
0
81.15
Tax
15.78
0
15.78
Provisions and contingencies
0
0
0.00
Profit After Tax
43.95
0
43.95
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
43.95
0
43.95
Share in Profit of Associates
0
0
0.00
Minority Interest
21.41
0
21.41
Other related items
0.00
0.00
0.00
Consolidated Net Profit
65.36
0
65.36
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
708.45
0
708.45
Earnings per share (EPS)
0.14
0
0.14
Diluted Earnings per share
0.14
0
0.14
Operating Profit Margin (Excl OI)
10.00%
0%
0.00
10.00%
Gross Profit Margin
14.32%
0%
0.00
14.32%
PAT Margin
5.01%
0%
0.00
5.01%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 87.79 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -14.96% vs -3.66% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 6.54 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 30.54% vs -40.29% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.24 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -0.38% vs 18.77% in Dec 2024
Annual - Interest
Interest 0.29 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -17.14% vs -14.63% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.00%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
